Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Overexpression of melatonin membrane receptors increases calcium-binding proteins and protects VSC4.1 motoneurons from glutamate toxicity through multiple mechanisms.

Das A, Wallace G 4th, Reiter RJ, Varma AK, Ray SK, Banik NL.

J Pineal Res. 2013 Jan;54(1):58-68. doi: 10.1111/j.1600-079X.2012.01022.x. Epub 2012 Jul 23.

PMID:
22823500
2.

The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-alpha toxicity involves membrane melatonin receptors.

Das A, McDowell M, Pava MJ, Smith JA, Reiter RJ, Woodward JJ, Varma AK, Ray SK, Banik NL.

J Pineal Res. 2010 Mar;48(2):157-69. doi: 10.1111/j.1600-079X.2009.00739.x. Epub 2010 Jan 17.

3.

Calpain activation in apoptosis of ventral spinal cord 4.1 (VSC4.1) motoneurons exposed to glutamate: calpain inhibition provides functional neuroprotection.

Das A, Sribnick EA, Wingrave JM, Del Re AM, Woodward JJ, Appel SH, Banik NL, Ray SK.

J Neurosci Res. 2005 Aug 15;81(4):551-62.

PMID:
15968645
4.

Cross-talk between IGF-1 and estrogen receptors attenuates intracellular changes in ventral spinal cord 4.1 motoneuron cells because of interferon-gamma exposure.

Park S, Nozaki K, Smith JA, Krause JS, Banik NL.

J Neurochem. 2014 Mar;128(6):904-18. doi: 10.1111/jnc.12520. Epub 2013 Dec 4.

5.

Gender-related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer.

León J, Casado J, Carazo A, Sanjuán L, Maté A, Muñoz de Rueda P, de la Cueva P, Quiles R, Ruíz S, Ruíz-Extremera A, Salmerón J.

Mol Carcinog. 2012 Aug;51(8):608-18. doi: 10.1002/mc.20832. Epub 2011 Aug 1.

PMID:
21809392
6.

Estrogen receptor agonists and estrogen attenuate TNF-α-induced apoptosis in VSC4.1 motoneurons.

Das A, Smith JA, Gibson C, Varma AK, Ray SK, Banik NL.

J Endocrinol. 2011 Feb;208(2):171-82. doi: 10.1677/JOE-10-0338. Epub 2010 Nov 10.

7.

Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers.

Niles LP, Armstrong KJ, Rincón Castro LM, Dao CV, Sharma R, McMillan CR, Doering LC, Kirkham DL.

BMC Neurosci. 2004 Oct 28;5:41.

8.

MiR-7-1 potentiated estrogen receptor agonists for functional neuroprotection in VSC4.1 motoneurons.

Chakrabarti M, Banik NL, Ray SK.

Neuroscience. 2014 Jan 3;256:322-33. doi: 10.1016/j.neuroscience.2013.10.027. Epub 2013 Oct 22.

9.

Calbindin-D28K is increased in the ventral horn of spinal cord by neuroprotective factors for motor neurons.

Spruill MM, Kuncl RW.

J Neurosci Res. 2015 Aug;93(8):1184-91. doi: 10.1002/jnr.23562. Epub 2015 Apr 24.

PMID:
25914366
10.

Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia.

Kilic U, Yilmaz B, Ugur M, Yüksel A, Reiter RJ, Hermann DM, Kilic E.

J Pineal Res. 2012 Mar;52(2):228-35. doi: 10.1111/j.1600-079X.2011.00932.x. Epub 2011 Sep 14.

PMID:
21913972
11.

Role of melatonin receptors in the effects of melatonin on BDNF and neuroprotection in mouse cerebellar neurons.

Imbesi M, Uz T, Manev H.

J Neural Transm (Vienna). 2008 Nov;115(11):1495-9. doi: 10.1007/s00702-008-0066-z. Epub 2008 May 21.

PMID:
18493705
12.

Gene structures, biochemical characterization and distribution of rat melatonin receptors.

Ishii H, Tanaka N, Kobayashi M, Kato M, Sakuma Y.

J Physiol Sci. 2009 Jan;59(1):37-47. doi: 10.1007/s12576-008-0003-9. Epub 2008 Dec 6.

PMID:
19340560
13.

Distribution of melatonin receptors in murine pancreatic islets.

Nagorny CL, Sathanoori R, Voss U, Mulder H, Wierup N.

J Pineal Res. 2011 May;50(4):412-7. doi: 10.1111/j.1600-079X.2011.00859.x. Epub 2011 Mar 1.

PMID:
21355877
14.

Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?

Jockers R, Maurice P, Boutin JA, Delagrange P.

Br J Pharmacol. 2008 Jul;154(6):1182-95. doi: 10.1038/bjp.2008.184. Epub 2008 May 19. Review.

15.

Regional upregulation of hippocampal melatonin MT2 receptors by valproic acid: therapeutic implications for Alzheimer's disease.

Bahna SG, Sathiyapalan A, Foster JA, Niles LP.

Neurosci Lett. 2014 Jul 25;576:84-7. doi: 10.1016/j.neulet.2014.05.056. Epub 2014 Jun 5.

PMID:
24909617
16.

The melatonin MT1 receptor axis modulates mutant Huntingtin-mediated toxicity.

Wang X, Sirianni A, Pei Z, Cormier K, Smith K, Jiang J, Zhou S, Wang H, Zhao R, Yano H, Kim JE, Li W, Kristal BS, Ferrante RJ, Friedlander RM.

J Neurosci. 2011 Oct 12;31(41):14496-507. doi: 10.1523/JNEUROSCI.3059-11.2011.

17.

Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress.

Das A, Belagodu A, Reiter RJ, Ray SK, Banik NL.

J Pineal Res. 2008 Sep;45(2):117-24. doi: 10.1111/j.1600-079X.2008.00582.x. Epub 2008 Mar 26.

18.

Melatonin signaling in mouse cerebellar granule cells with variable native MT1 and MT2 melatonin receptors.

Imbesi M, Uz T, Dzitoyeva S, Giusti P, Manev H.

Brain Res. 2008 Aug 28;1227:19-25. doi: 10.1016/j.brainres.2008.06.082. Epub 2008 Jun 28.

19.

Expression of melatonin receptor (MT1) and interaction between melatonin and estrogen in endometrial cancer cell line.

Watanabe M, Kobayashi Y, Takahashi N, Kiguchi K, Ishizuka B.

J Obstet Gynaecol Res. 2008 Aug;34(4):567-73. doi: 10.1111/j.1447-0756.2008.00818.x.

PMID:
18937711
20.

Analysis of the daily changes of melatonin receptors in the rat liver.

Venegas C, García JA, Doerrier C, Volt H, Escames G, López LC, Reiter RJ, Acuña-Castroviejo D.

J Pineal Res. 2013 Apr;54(3):313-21. doi: 10.1111/jpi.12019. Epub 2012 Oct 30.

PMID:
23110416

Supplemental Content

Support Center